Showing results (41-50 of 91) with videos related to
Sort By:
Pageof 10
British Medical Journal|October 25, 1975
Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemiaP A Lorkin, A D Stephens, M E Beard, et al.British Journal of Cancer|March 1, 1988
Oral urea in the treatment of secondary tumours in the liverP I Clark, M L Slevin, J A Webb, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.Lancet (London, England)|July 8, 1978
Post-treatment laparotomy in the management of Hodgkin's diseaseS B Sutcliffe, D Katz, A G Stansfeld, et al.European Journal of Cancer & Clinical Oncology|November 1, 1985
Variable bioavailability following repeated oral doses of etoposideV J Harvey, M L Slevin, S P Joel, et al.Cell|February 13, 1987
The Saccharomyces and Drosophila heat shock transcription factors are identical in size and DNA binding propertiesG Wiederrecht, D J Shuey, W A Kibbe, et al.Acta Clinica Belgica|January 1, 1989
Autoimmune haemolytic anaemia associated with malignant peritoneal mesotheliomaD L Selleslag, R J Geraghty, T S Ganesan, et al.International Journal of Clinical Pharmacology Research|January 1, 1992
Protein binding of indomethacin, methotrexate and morphine in patients with cancerR Raveendran, W M Heybroek, M Caulfield, et al.British Journal of Cancer|April 1, 1988
Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphomaM A Richards, J A Webb, S E Jewell, et al.British Journal of Cancer|December 1, 1990
Phase II trial of UFT in advanced colorectal and gastric cancerS T Malik, D Talbot, P I Clarke, et al.Pageof 10